Fourpath Capital Management’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,706
Closed -$214K 219
2025
Q4
$214K Sell
1,706
-76
-4% -$9.68K 0.03% 218
2025
Q3
$239K Sell
1,782
-25
-1% -$3.28K 0.03% 201
2025
Q2
$246K Sell
1,807
-12
-0.7% -$1.58K 0.04% 204
2025
Q1
$241K Sell
1,819
-8
-0.4% -$1.02K 0.04% 196
2024
Q4
$207K Sell
1,827
-27
-1% -$3.12K 0.04% 216
2024
Q3
$211K Buy
+1,854
New +$203K 0.04% 217
2022
Q1
Sell
-1,706
Closed -$240K 155
2021
Q4
$240K Buy
+1,706
New +$218K 0.09% 144

Other funds holding ABT

Fourpath Capital Management's ABT Position: Q1 2026 in Review

Fourpath Capital Management sold out of Abbott (ABT) in Q1 2026, closing a stake of 1,706 shares — an estimated $214K sold.

Fourpath Capital Management first reported a position in ABT in Q4 2021 and held it in 7 quarters. The position peaked at $246K in Q2 2025. 3,084 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • Fourpath Capital Management reported no remaining Abbott position as of Q1 2026 after selling out during the quarter.
  • Fourpath Capital Management sold 1,706 Abbott shares in Q1 2026, an estimated $214K.
  • Fourpath Capital Management first reported a position in Abbott in Q4 2021 and held it in 7 quarters.
  • Fourpath Capital Management's Abbott position peaked at $246K in Q2 2025.
  • 3,084 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Fourpath Capital Management's 13F filing for Q1 2026, filed 1 May 2026.